Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB019549

CD43/Sialophorin Mouse anti-Human, DyLight 488, Clone: DF-T1, Novus Biologicals™
SDP

Catalog No. NB019549 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB019549 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB019549 Supplier Novus Biologicals Supplier No. NBP233140G100UL
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

CD43/Sialophorin Monoclonal specifically detects CD43/Sialophorin in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.

Specifications

Antigen CD43/Sialophorin
Applications ELISA
Classification Monoclonal
Clone DF-T1
Conjugate DyLight 488
Formulation 50mM Sodium Borate
Gene Alias CD43 antigen, CD43), Galactoglycoprotein, GALGP, Leukocyte sialoglycoprotein, Sialophorin, sialophorin (gpL115, leukosialin, CD43)
Host Species Mouse
Immunogen Myeloblastic KG1 cells were used as the immunogen for this antibody.
Purification Method Protein G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 6693
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.